X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
female (9) 9
male (9) 9
middle aged (8) 8
patients (8) 8
aged (7) 7
orthopedics (6) 6
quality of life (6) 6
research (6) 6
surgery (6) 6
medical research (5) 5
medicine, general & internal (5) 5
trauma (5) 5
adult (4) 4
analysis (4) 4
care and treatment (4) 4
health aspects (4) 4
hospitals (4) 4
patient outcomes (4) 4
reproducibility of results (4) 4
sf-36 (4) 4
treatment outcome (4) 4
1506 (3) 3
1737 (3) 3
abridged index medicus (3) 3
cancellous screws (3) 3
clinical rating systems (3) 3
cross-cultural adaptation (3) 3
dosage and administration (3) 3
ethics (3) 3
fracture (3) 3
fractures (3) 3
function index (3) 3
injuries (3) 3
language (3) 3
mortality (3) 3
mutation (3) 3
netherlands (3) 3
pain (3) 3
prospective studies (3) 3
reliability (3) 3
reoperation (3) 3
responsiveness (3) 3
risk factors (3) 3
science (3) 3
studies (3) 3
surveys and questionnaires (3) 3
validity (3) 3
[ sdv.mhep ] life sciences [q-bio]/human health and pathology (2) 2
adaptation (2) 2
aged, 80 and over (2) 2
aneurysms (2) 2
ankle (2) 2
aspirin (2) 2
behavioral sciences (2) 2
bleeding (2) 2
cardiovascular diseases (2) 2
cardiovascular diseases - mortality (2) 2
cardiovascular diseases - prevention & control (2) 2
cerebral infarction (2) 2
clinical medicine (2) 2
clopidogrel (2) 2
cohort studies (2) 2
complications (2) 2
conference papers and proceedings (2) 2
coronary vessels (2) 2
critical care medicine (2) 2
double-blind method (2) 2
drug therapy (2) 2
drug therapy, combination (2) 2
europe (2) 2
femoral neck fractures (2) 2
femoral neck fractures - surgery (2) 2
genes (2) 2
genetics (2) 2
hemorrhage (2) 2
hemorrhage - chemically induced (2) 2
hip joint (2) 2
human health and pathology (2) 2
intensive care units (2) 2
internal fixation (2) 2
joint surgery (2) 2
lesser toes (2) 2
life sciences (2) 2
management (2) 2
marfan syndrome (2) 2
marfan syndrome - complications (2) 2
medicine (2) 2
medicine & public health (2) 2
medicine and health sciences (2) 2
medicine, experimental (2) 2
metaanalysis (2) 2
multidisciplinary sciences (2) 2
myocardial infarction (2) 2
normative data (2) 2
outcomes (2) 2
platelet aggregation inhibitors - adverse effects (2) 2
prevention (2) 2
quality (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2015, Volume 65, Issue 3, pp. 246 - 254
Journal Article
HeartRhythm Case Reports, ISSN 2214-0271, 01/2017, Volume 3, Issue 1, pp. 73 - 77
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 19, pp. 1791 - 1800
Patients with myocardial infarction 1 to 3 years previously were assigned to ticagrelor, 90 or 60 mg twice daily, or to placebo, in addition to low-dose... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | CLOPIDOGREL | MANAGEMENT | ESC GUIDELINES | AMERICAN-COLLEGE | PREVENTION | ASSOCIATION TASK-FORCE | ACUTE CORONARY SYNDROMES | PRASUGREL | ASPIRIN | Purinergic P2Y Receptor Antagonists - administration & dosage | Double-Blind Method | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Risk | Secondary Prevention | Adenosine - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Intracranial Hemorrhages - chemically induced | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - mortality | Female | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Dose-response relationship (Biochemistry) | Treatment outcome | Care and treatment | Safety and security measures | Analysis | Dosage and administration | Ticagrelor | Heart attack | Risk factors | Myocardial infarction | Cerebral infarction | Aspirin | Stroke | Heart attacks | Hemorrhage | Long term | Patients | Thrombolysis | Bleeding | Blood platelets | Antagonist drugs | Cardiovascular diseases | Drug therapy | Life Sciences | Human health and pathology
Journal Article